Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2023-05-23T00:00:00.000+01:00
Ongoing

VIKTORIA-1

VIKTORIA-1
Breast cancer

Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of Gedatolisib plus Fulvestrant with or without Palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of Gedatolisib plus Fulvestrant with or without Palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Breast

Study Phase

III

Trial Identifiers

Registration number: NCT05501886

https://clinicaltrials.gov/study/NCT05501886

GenesisCare Location(s)

St Andrew's Hospital (Oncology) 

St Andrew's Hospital (Oncology)  :::
Principal Investigator(s)

Dr Nick Murray

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.